Randhawa Simrat exercised Options covering 23,124 Dianthus Therapeutics shares across three transactions on 2026-09-01, with exercise prices from $17.88 to $22.07 per share. The post-transaction balances distinguish Simrat’s remaining 4,000 shares from 87,500 derivative securities, giving investors the reported ownership position after the transactions.

Key Highlights

  • Randhawa Simrat is Dianthus Therapeutics’ executive vice president and head of research and development.
  • Simrat owned 27,124 shares after exercising the options and 4,000 shares after selling 23,124 shares.
  • Simrat held 87,500 derivative securities after exercises recorded at $0 per share.

Dianthus Therapeutics, Inc. /DE/ (NASDAQ: DNTH) executive vice president and head of Research and Development Randhawa Simrat exercised options covering 23,124 shares in three transactions on 1 September 2026. The exercise prices ranged from $17.88 to $22.07 per share.

Three Option Exercises Followed by Share Sales

Simrat’s option exercises used transaction code M and were recorded at $0 per share for 23,124 derivative securities. After those exercises, Simrat owned 27,124 shares. Simrat then sold 23,124 shares across three separate transactions using transaction code S, with sale prices ranging from $105.19 to $106.74 per share. Following the sales, Simrat owned 4,000 shares. Following these transactions, Simrat owned 87,500 derivative securities.